OBJECTIVES: To compare the clinical features and course of major depressive episodes (MDEs) occurring in subjects with bipolar I disorder (BD-I), bipolar II disorder (BD-II), and major depressive disorder (MDD). METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002), a nationally representative face-to-face survey of more than 43000 adults in the USA, including 5695 subjects with lifetime MDD, 935 with BD-I and lifetime MDE, and 494 with BD-II and lifetime MDE. Differences on sociodemographic characteristics and clinical features, course, and treatment patterns of MDE were analyzed. RESULTS: Most depressive symptoms, family psychiatric history, anxiety disorders, alcohol and drug use disorders, and personality disorders were more frequent-and number of depressive symptoms per MDE was higher-among subjects with BD-I, followed by BD-II, and MDD. BD-I individuals experienced a higher number of lifetime MDEs, had a poorer quality of life, and received significantly more treatment for MDE than BD-II and MDD subjects. Individuals with BD-I and BD-II experienced their first mood episode about ten years earlier than those with MDD (21.2, 20.5, and 30.4 years, respectively). CONCLUSIONS: Our results support the existence of a spectrum of severity of MDE, with highest severity for BD-I, followed by BD-II and MDD, suggesting the utility of dimensional assessments in current categorical classifications.
OBJECTIVES: To compare the clinical features and course of major depressive episodes (MDEs) occurring in subjects with bipolar I disorder (BD-I), bipolar II disorder (BD-II), and major depressive disorder (MDD). METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002), a nationally representative face-to-face survey of more than 43000 adults in the USA, including 5695 subjects with lifetime MDD, 935 with BD-I and lifetime MDE, and 494 with BD-II and lifetime MDE. Differences on sociodemographic characteristics and clinical features, course, and treatment patterns of MDE were analyzed. RESULTS: Most depressive symptoms, family psychiatric history, anxiety disorders, alcohol and drug use disorders, and personality disorders were more frequent-and number of depressive symptoms per MDE was higher-among subjects with BD-I, followed by BD-II, and MDD. BD-I individuals experienced a higher number of lifetime MDEs, had a poorer quality of life, and received significantly more treatment for MDE than BD-II and MDD subjects. Individuals with BD-I and BD-II experienced their first mood episode about ten years earlier than those with MDD (21.2, 20.5, and 30.4 years, respectively). CONCLUSIONS: Our results support the existence of a spectrum of severity of MDE, with highest severity for BD-I, followed by BD-II and MDD, suggesting the utility of dimensional assessments in current categorical classifications.
Authors: David A Solomon; Andrew C Leon; Jack D Maser; Christine J Truman; William Coryell; Jean Endicott; Jedediah J Teres; Martin B Keller Journal: J Clin Psychiatry Date: 2006-03 Impact factor: 4.384
Authors: Ronald C Kessler; Hagop S Akiskal; Jules Angst; Margaret Guyer; Robert M A Hirschfeld; Kathleen R Merikangas; Paul E Stang Journal: J Affect Disord Date: 2006-09-25 Impact factor: 4.839
Authors: Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2007-05
Authors: Timothy E Wilens; Joseph Biederman; Joel Adamson; Michael Monuteaux; Aude Henin; Stephanie Sgambati; Alison Santry; Stephen V Faraone Journal: Biol Psychiatry Date: 2007-05-03 Impact factor: 13.382
Authors: Jakub Z Konarski; Roger S McIntyre; Sidney H Kennedy; Shahryar Rafi-Tari; Joanna K Soczynska; Terence A Ketter Journal: Bipolar Disord Date: 2008-02 Impact factor: 6.744
Authors: Carmen Moreno; Deborah S Hasin; Celso Arango; Maria A Oquendo; Eduard Vieta; Shangmin Liu; Bridget F Grant; Carlos Blanco Journal: Bipolar Disord Date: 2012-12-12 Impact factor: 6.744
Authors: Carlos Blanco; Wilson M Compton; Tulshi D Saha; Benjamin I Goldstein; W June Ruan; Boji Huang; Bridget F Grant Journal: J Psychiatr Res Date: 2016-10-07 Impact factor: 4.791